News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
182,343 Results
Type
Article (32295)
Company Profile (10)
Press Release (150036)
Multimedia
Podcasts (12)
Webinars (10)
Section
Business (54863)
Career Advice (365)
Deals (3249)
Drug Delivery (17)
Drug Development (24213)
Employer Resources (32)
FDA (3413)
Job Trends (3226)
News (81122)
Policy (4244)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Pharm Country Standard (1)
40 Under 40 (2)
Academia (2466)
Academic (1)
Accelerated approval (20)
ADA (13)
Adcomms (9)
Allergies (60)
Alliances (10925)
ALS (82)
Alzheimer's disease (709)
Antibody-drug conjugate (ADC) (123)
Approvals (3664)
Artificial intelligence (198)
ASCO (116)
Autoimmune disease (96)
Automation (15)
Bankruptcy (19)
Belgium (9)
Best Places to Work (2692)
BIO (7)
Biologics (30)
BIOSECURE Act (3)
Biosimilars (19)
BioSpace Insights (30)
Biotechnology (10)
Bispecific (15)
Bladder cancer (48)
Brain cancer (48)
Breast cancer (259)
Cancer (2128)
Cardiovascular disease (147)
Career advice (345)
Career pathing (11)
CAR-T (114)
CDC (24)
CDMO (36)
Celiac Disease (1)
Cell therapy (288)
Cervical cancer (17)
Clinical research (20932)
Collaboration (506)
Commercialization (16)
Company closure (1)
Compensation (31)
Complete response letters (8)
COVID-19 (1225)
CRISPR (41)
CRO (2)
C-suite (1038)
Cystic fibrosis (36)
Data (3499)
Decentralized trials (2)
Denatured (8)
Depression (61)
Dermatology (57)
Diabetes (197)
Diagnostics (1915)
Digital health (14)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (99)
Drug pricing (14)
Drug shortages (5)
Duchenne muscular dystrophy (57)
Earnings (6958)
Editorial (12)
Employer branding (2)
Employer resources (31)
ESMO (125)
Events (19932)
Executive appointments (792)
Eye disease (7)
FDA (4346)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (4)
Frontotemporal dementia (12)
Funding (614)
Gene editing (81)
Generative AI (9)
Gene therapy (198)
GLP-1 (201)
Government (1035)
Grass and pollen (1)
Guidances (32)
Healthcare (5156)
Hematology (72)
HIV (30)
Huntington's disease (18)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (45)
Immunology and inflammation (33)
Immuno-oncology (38)
Indications (57)
Infectious disease (1342)
Inflammatory bowel disease (69)
Inflation Reduction Act (1)
Influenza (45)
Intellectual property (58)
Interviews (42)
IPO (1473)
IRA (8)
Job creations (578)
Job search strategy (318)
JPM (4)
Kidney cancer (10)
Kidney disease (59)
Labor market (19)
Layoffs (43)
Leadership (7)
Legal (687)
Licensing (17)
Liver cancer (33)
Longevity (6)
Lung cancer (252)
Lung diease (9)
Lymphoma (182)
Machine learning (16)
Management (9)
Manufacturing (166)
Marketing (4)
MASH (88)
Medical affairs (4)
Medical device (3248)
Medtech (3312)
Melanoma (70)
Mergers & acquisitions (1907)
Metabolic disorders (400)
mRNA (78)
Multiple sclerosis (70)
Multispecific (1)
NASH (5)
Netherlands (13)
Neurodegenerative disease (182)
Neuropsychiatric disorders (22)
Neuroscience (1289)
Neurotech (1)
NextGen: Class of 2026 (1801)
Non-profit (1747)
Now hiring (9)
Obesity (108)
Opinion (46)
Ovarian cancer (107)
Pain (68)
Pancreatic cancer (125)
Parkinson's disease (144)
Partnered (6)
Patents (109)
Patient advocacy (1)
Patient recruitment (273)
Patient selection (26)
Peanut (22)
People (34683)
Peptides (9)
Phase 1 (6556)
Phase 2 (9571)
Phase 3 (6465)
Pipeline (2955)
Policy (68)
Postmarket research (969)
Preclinical (3292)
Press Release (25)
Prostate cancer (113)
Psychedelics (20)
Radioligand (1)
Radiopharmaceuticals (108)
Rare diseases (319)
Real estate (1295)
Recruiting (17)
Regenerative medicine (10)
Regulatory (3889)
Reports (6)
Research institute (1430)
Resumes & cover letters (23)
Rett syndrome (12)
RNA editing (10)
RSV (12)
Schizophrenia (38)
Series A (93)
Series B (43)
Sickle cell disease (41)
Spinal muscular atrophy (49)
Sponsored (9)
Startups (1138)
Stem cells (2)
Stomach cancer (1)
Substance use disorders (8)
Supply chain (8)
Switzerland (7)
Tariffs (9)
Tax incentives (1)
The Weekly (4)
Vaccines (352)
Venture capital (33)
Weight loss (58)
Wet AMD (1)
Women's health (39)
Worklife (3)
Date
Today (29)
Last 7 days (167)
Last 30 days (726)
Last 365 days (6480)
2026 (5917)
2025 (6357)
2024 (7540)
2023 (9321)
2022 (11577)
2021 (13337)
2020 (12825)
2019 (12191)
2018 (9045)
2017 (8769)
2016 (8952)
2015 (10263)
2014 (7848)
2013 (7627)
2012 (7582)
2011 (7593)
2010 (6832)
Location
Africa (267)
Alabama (21)
Alaska (3)
Arizona (91)
Arkansas (7)
Asia (11079)
Australia (2751)
California (3540)
Canada (952)
China (427)
Colorado (160)
Connecticut (139)
Delaware (106)
Europe (30111)
Florida (438)
Georgia (128)
Hawaii (1)
Idaho (13)
Illinois (285)
India (16)
Indiana (149)
Iowa (10)
Japan (191)
Kansas (24)
Kentucky (9)
Louisiana (13)
Maine (19)
Maryland (378)
Massachusetts (2364)
Michigan (69)
Minnesota (157)
Mississippi (5)
Missouri (52)
Montana (6)
Nebraska (6)
Nevada (50)
New Hampshire (13)
New Jersey (911)
New Mexico (10)
New York (971)
North Carolina (517)
North Dakota (4)
Northern California (1957)
Ohio (141)
Oklahoma (9)
Oregon (14)
Pennsylvania (621)
Puerto Rico (5)
Rhode Island (27)
South America (311)
South Carolina (19)
Southern California (1321)
Tennessee (78)
Texas (597)
United States (12212)
Utah (110)
Virginia (90)
Washington D.C. (20)
Washington State (305)
West Virginia (2)
Wisconsin (37)
182,343 Results for "emory university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology
October 29, 2026
·
5 min read
Press Releases
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
June 18, 2026
·
6 min read
Press Releases
Stellaromics Expands Pyxa™ 3D Spatial Transcriptomics Beta Program with Installation at Emory University School of Medicine
January 29, 2026
·
3 min read
Press Releases
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
March 26, 2026
·
6 min read
Press Releases
Zoher F. Kapasi, PhD, PT, Named Provost of Thomas Jefferson University
September 9, 2026
·
4 min read
Press Releases
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
December 19, 2025
·
7 min read
Press Releases
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
August 27, 2025
·
5 min read
Lone Star Bio
InGeneron Announces Encouraging Results from Emory University’s 480-Patient Phase III Knee Osteoarthritis Trial
InGeneron, Inc., a clinical stage biotechnology company, announces the publication of a Phase III 480-patient clinical trial sponsored by Emory University (Atlanta, GA, USA).
November 3, 2023
·
6 min read
Press Releases
Biosenta Highlights Independent University of Calgary Research Validating Tri-Filler(TM) Antimicrobial Technology
University of Calgary research demonstrates more than 200-fold improvement in antibacterial performance while Biosenta advances commercialization
July 21, 2026
·
5 min read
Press Releases
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology
June 16, 2025
·
5 min read
1 of 18,235
Next